Synonyms of Triploid Syndrome
- 2n/3n Mixoploidy
- 3n Syndrome
- Chromosome Triploidy Syndrome
- Diploid/Triploid Mixoploidy
- Triploidy Syndrome
- No subdivisions found.
Triploid Syndrome is an extremely rare chromosomal disorder. Individuals with triploid syndrome have three of every chromosome for a total of sixty-nine rather than the normal forty-six chromosomes. Babies with Triploid Syndrome usually are lost through early miscarriage. However, some infants have been born and survived as long as five months. Affected infants are usually small and have multiple birth defects. Those that survive are usually mosaic, meaning that some cells have the normal number of 46 chromosomes and some cells have a complete extra set of chromosomes.
Triploid Syndrome may include larger than normal size placenta, lack of prenatal skeletal growth, widely spaced eyes (ocular hypertelorism), low nasal bridge, low-set malformed ears and a smaller than normal sized jaw. The third and fourth fingers of the hands may be connected and the hands may have unusual simian creases. The infant may have congenital heart defects and genital abnormalities may be present in males. There may be abnormal brain development, lack of development of the adrenal glands and cystic kidneys. Growth of the brain or spinal cord outside of the body (neural tube defects), openings in the abdominal wall, an unusually shaped skull and cleft lip and/or palate have also been observed. There may also be liver and gallbladder deformities, twisted colon and finger and toe deformities. Individuals who are mosaic will survive longer than those with complete triploidy but usually have mental retardation.
The pregnant mother carrying a triploid fetus sometimes experiences extremes of high blood pressure (hypertension), swelling (edema), and excretion of albumin in the urine (albuminuria). This condition is called toxemia or preeclampsia. Triploidy is frequently diagnosed in pregnancies in which there is a cystic placenta (partial mole). The Triploid Syndrome has been associated with pregnancies that occur soon after oral contraceptives are discontinued or after long menstrual cycles. Triploidy has been reported in conceptions that occurred following in vitro fertilization and in conceptions after a history of repeated miscarriages.
Triploid Syndrome is caused by a complete extra set of chromosomes. The triplication of the chromosomes is most often caused by fertilization of an egg by two sperm. Triploidy can also be caused by fertilization of an egg by a sperm that has an extra set of chromosomes or fertilization of an egg that has an extra set of chromosomes by a normal sperm. This disorder does not run in families and is not associated with maternal or paternal age.
Triploidy occurs slightly more often in males than females.
Symptoms of the following disorders are caused by duplication, triplication or deletion of chromosomes:
Trisomies are very rare genetic disorders characterized by a triple chromosome. The most common symptom of the trisomies is mental retardation. Chromosomes are found in the nucleus of all body cells. They carry the genetic characteristics of each individual. Pairs of human chromosomes are numbered from 1 through 22, with an unequal 23rd pair of X and Y chromosomes for males, and two X chromosomes for females. People with a Trisomy have an extra chromosome added to one of the normal pairs. The triplication of the chromosome may be partial, either an extra short arm (p+) or an extra long arm (q+). Defects are classified by the name of the abnormal chromosome pair and which portion of the chromosome is affected. (For more information on this disorder, choose "Trisomy" as your search term in the Rare Disease Database.)
Down Syndrome is the most common and readily identifiable genetic condition caused by a chromosomal abnormality. One additional chromosome is present. Children with Down Syndrome have some degree of mental retardation. That can range from mild to profound. However, most children with Down Syndrome function in the mild to moderate range. Many of the children can be educated in the public schools, learn basic academic and pre-vocational skills with special training, and perform many daily living activities independently. (For more information on this disorder, choose "Down" as your search term in the Rare Disease Database.)
Chromosome 11, Monosomy 11q (Jacobsen Syndrome) is a rare genetic disorder affecting the long arm of chromosome 11. The disorder may be characterized by a narrow protruding forehead, eye problems, abnormally shaped nose and mouth and mental retardation. This syndrome is caused by a deletion on the long arm (q) of chromosome 11. The severity and type of abnormality depends upon the size and location of the missing chromosome piece. The cause of the chromosome break itself is unknown. (For more information on this disorder, choose "Chromosome 11, Monosomy 11q" as your search term in the Rare Disease Database.)
18p Syndrome is a deletion of the short arm (p) of chromosome 18. It is characterized by unusual facial features and mild to severe mental retardation. This syndrome may also include growth deficiency, diminished muscle tension and a smaller than normal sized brain. There may also be behavior problems and delayed speech. (For more information on this disorder, choose "18p" as your search term in the Rare Disease Database.)
Triploid syndrome can be diagnosed thorough cytogenetic (chromosome) analysis on a blood specimen. It can be diagnosed prenatally through cytogenetic analysis of cells obtained through amniocentesis or chorionic villus sampling. Abnormal levels of specific maternal blood proteins such as alpha-fetoprotein, human chorionic gonadotropin, estriol and pregnancy-assisted plasma protein-A have been associated with an increased risk for triploidy.
Treatment of triploid syndrome is symptomatic and supportive.
Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.
For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:
Tollfree: (800) 411-1222
TTY: (866) 411-1010
For information about clinical trials sponsored by private sources, contact:
Triploid Syndrome Resources
Jones KL, Ed. Smith's Recognizable patterns of Human Malformation. 4th ed. W.B. Saunders Company. 1998:32-35.
Doshi N, et al. Morphologic anomalies in triploid liveborn fetuses. Hum Path. 1983;14(4):716-723.
Beatty RA. The origin of human triploidy: An integration of qualitative and quantitative evidence. Ann Hum Genet (Cambridge). 1978;41:229-314.
Graham JM, et al. Triploidy: Pregnancy complications and clinical findings in seven cases. Prenat Diag. 1989;9:409-19.
Wertelecki W, et al. The clinical syndrome of triploidy. Obst Gyn. 1976;47:69-76.
Cerakushansky G, et al. Diploid/triploid mosacicism: Further delination of the phenotype. Am J Med Genet. 1994;52:399-401.
Edwards MJ, et al. Clinical features of diploid/polyploid mixoploidy in older individuals. Pediat Res. 1989;25:76.
Graham JM, et al. Diploid-Triploid mixoploidy: Clinical and cytogenetic aspects. Pediatrics. 1981;68:23-8.
Angell RR, et al. Chromosome studies in human in vitro fertilization. Hum Genet. 1986;72:333-339.
Benn PA, et al. Second trimester maternal serum analytes in triploid pregnancies: correlation with phenotype and sex chromosome complement. Prenat Diag. 2001;21:680-686.
Carp H, et al. Karyotype of the abortus in recurrent miscarriage. Fertil Steril 2001;75:678-682.
Zaragoza MV et al. Parental origin and phenotype of triploidy in spontaneous abortions: predominance of diandry and association with the partial hydatidiform mole. Am J Hum Genet. 2000;66:1807-1820.
The information in NORD’s Rare Disease Database is for educational purposes only. It should never be used for diagnostic or treatment purposes. If you have questions regarding a medical condition, always seek the advice of your physician or other qualified health professional. NORD’s reports provide a brief overview of rare diseases. For more specific information, we encourage you to contact your personal physician or the agencies listed as “Resources” on this report.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.
Copyright ©1989, 2003
Report last updated: 2008/05/21 00:00:00 GMT+0
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.